<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVEMetabolic syndrome is a multiplex disorder and puts patients on the road to type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:e sem="disease" ids="C0003972" disease_type="Disease or Syndrome" abbrv="ascvd">atherosclerotic cardiovascular diseases</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>However, a surrogate biomarker in plasma or urine in fully reflecting features of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> has not been explored.RESEARCH DESIGN AND METHODSUrine metabolomics has potential utility in metabolic profiling because urine metabolites analysis reflects global outflux of metabolic change </plain></SENT>
<SENT sid="2" pm="."><plain>Accordingly, we collected data on subjects (n = 99) with overweight, <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e>, <z:hpo ids='HP_0000822'>hypertension</z:hpo> or <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo> and took a metabolomics approach to analyze the metabolites of urine revealed in <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> by high-performance liquid chromatography-time-of-flight mass spectrometry and elicit potential biomarkers to picture <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e>.RESULTSOur results revealed that the urine <z:chebi fb="0" ids="7563">nicotinuric acid</z:chebi> value of subjects with <z:mp ids='MP_0002055'>diabetes</z:mp> (HbA(1c) ≥6.5% or those receiving <z:mp ids='MP_0002055'>diabetes</z:mp> medications) (n = 25) was higher than subjects without <z:mp ids='MP_0002055'>diabetes</z:mp> (n = 37) (221 ± 31 vs. 152 ± 13 × 10(3) mAU, P = 0.0268) </plain></SENT>
<SENT sid="3" pm="."><plain>Moreover, urinary <z:chebi fb="0" ids="7563">nicotinuric acid</z:chebi> level was positively correlated with body mass index, blood pressure, total cholesterol, <z:chebi fb="1" ids="47774">low-density lipoprotein cholesterol</z:chebi>, triacylglycerol and high sensitivity C-reactive protein, but negatively correlated with <z:chebi fb="1" ids="47775">high-density lipoprotein cholesterol</z:chebi>.CONCLUSIONSThis is the first study, to our knowledge, to propose that <z:chebi fb="0" ids="7563">nicotinuric acid</z:chebi> represents an important pathogenic mechanism in process from <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> to <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:e sem="disease" ids="C0003972" disease_type="Disease or Syndrome" abbrv="ascvd">atherosclerotic cardiovascular disease</z:e> </plain></SENT>
</text></document>